Aclaris Therapeutics, INC. (ACRS) SEC Filings — 2024
27 SEC filings for Aclaris Therapeutics, INC. (ACRS) in 2024.
Filings
- Aclaris Therapeutics, INC. SC 13G Filing — SC 13G · Nov 25, 2024
- Aclaris Therapeutics, INC. SC 13G Filing — SC 13G · Nov 22, 2024
- Aclaris Therapeutics, INC. SC 13G Filing — SC 13G · Nov 21, 2024
- Aclaris Therapeutics Files 8-K on Agreements & Officer Changes — 8-K · Nov 18, 2024
- Aclaris Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Aclaris Therapeutics Reports Net Liability — 10-Q · Nov 6, 2024
- Aclaris Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 9, 2024
- Aclaris Therapeutics Reports Q2 2024 Financials — 10-Q · Aug 7, 2024
- Aclaris Therapeutics Files 8-K — 8-K · Jul 16, 2024
- Aclaris Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Jul 8, 2024
- Aclaris Therapeutics Files 8-K on Shareholder Vote — 8-K · Jun 7, 2024
- Aclaris Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Aclaris Therapeutics, Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 25, 2024
- Aclaris Therapeutics Announces Board and Executive Changes — 8-K · Mar 19, 2024
- Aclaris Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
- Aclaris Therapeutics, INC. SC 13G Filing — SC 13G · Feb 14, 2024
- Aclaris Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Aclaris Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Aclaris Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Aclaris Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Aclaris Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BML Investment Partners Amends Aclaris Therapeutics Stake — SC 13G/A · Feb 8, 2024
- Aclaris Amends 8-K on Executive Changes, Compensation — 8-K/A · Feb 5, 2024
- Millennium Management Updates Aclaris Therapeutics Stake — SC 13G/A · Feb 1, 2024
- BlackRock Amends Aclaris Therapeutics Stake, Remains Passive Investor — SC 13G/A · Jan 25, 2024
- Aclaris Therapeutics Files 8-K on Operations, Officer Changes — 8-K · Jan 19, 2024
- BML Investment Partners Discloses New Stake in Aclaris Therapeutics — SC 13G · Jan 16, 2024